285 related articles for article (PubMed ID: 25418900)
21. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
Lobo J; Ohashi R; Amin MB; Berney DM; Compérat EM; Cree IA; Gill AJ; Hartmann A; Menon S; Netto GJ; Raspollini MR; Rubin MA; Tan PH; Tickoo SK; Tsuzuki T; Turajlic S; Zhou M; Srigley JR; Moch H
Histopathology; 2022 Oct; 81(4):426-438. PubMed ID: 35596618
[TBL] [Abstract][Full Text] [Related]
22. Renal cell carcinoma: Evolving and emerging subtypes.
Crumley SM; Divatia M; Truong L; Shen S; Ayala AG; Ro JY
World J Clin Cases; 2013 Dec; 1(9):262-75. PubMed ID: 24364021
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas.
Rao Q; Xia QY; Cheng L; Zhou XJ
Chin J Cancer Res; 2016 Feb; 28(1):29-49. PubMed ID: 27041925
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.
Alshenawy HA
Pathol Oncol Res; 2015 Sep; 21(4):893-9. PubMed ID: 25712789
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
26. What's new in the WHO 2022 classification of kidney tumours?
Alaghehbandan R; Siadat F; Trpkov K
Pathologica; 2022 Feb; 115(1):8-22. PubMed ID: 36645398
[TBL] [Abstract][Full Text] [Related]
27. Cystic clear cell papillary renal cell carcinoma: is it related to multilocular clear cell cystic neoplasm of low malignant potential?
Brimo F; Atallah C; Li G; Srigley JR
Histopathology; 2016 Apr; 68(5):666-72. PubMed ID: 26256827
[TBL] [Abstract][Full Text] [Related]
28. Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.
Hayes M; Peckova K; Martinek P; Hora M; Kalusova K; Straka L; Daum O; Kokoskova B; Rotterova P; Pivovarčikova K; Branzovsky J; Dubova M; Vesela P; Michal M; Hes O
Virchows Arch; 2015 Mar; 466(3):313-22. PubMed ID: 25544614
[TBL] [Abstract][Full Text] [Related]
29. Grading of renal cell carcinoma.
Delahunt B; Eble JN; Egevad L; Samaratunga H
Histopathology; 2019 Jan; 74(1):4-17. PubMed ID: 30565310
[TBL] [Abstract][Full Text] [Related]
30. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer.
Williamson SR; Gill AJ; Argani P; Chen YB; Egevad L; Kristiansen G; Grignon DJ; Hes O
Am J Surg Pathol; 2020 Jul; 44(7):e47-e65. PubMed ID: 32251007
[TBL] [Abstract][Full Text] [Related]
31. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
[TBL] [Abstract][Full Text] [Related]
32. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K; Williamson SR; Gill AJ; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Hes O
Mod Pathol; 2021 Jun; 34(6):1167-1184. PubMed ID: 33526874
[TBL] [Abstract][Full Text] [Related]
33. Morphological spectrum of renal cell carcinoma, unclassified: an analysis of 136 cases.
Perrino CM; Grignon DJ; Williamson SR; Idrees MT; Eble JN; Cheng L
Histopathology; 2018 Jan; 72(2):305-319. PubMed ID: 28833389
[TBL] [Abstract][Full Text] [Related]
34. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.
Delahunt B; Cheville JC; Martignoni G; Humphrey PA; Magi-Galluzzi C; McKenney J; Egevad L; Algaba F; Moch H; Grignon DJ; Montironi R; Srigley JR;
Am J Surg Pathol; 2013 Oct; 37(10):1490-504. PubMed ID: 24025520
[TBL] [Abstract][Full Text] [Related]
35. New and emerging renal entities: a perspective post-WHO 2016 classification.
Trpkov K; Hes O
Histopathology; 2019 Jan; 74(1):31-59. PubMed ID: 30565301
[TBL] [Abstract][Full Text] [Related]
36. Recent classification of renal epithelial tumors.
Kuroda N; Tanaka A
Med Mol Morphol; 2014 Jun; 47(2):68-75. PubMed ID: 23529139
[TBL] [Abstract][Full Text] [Related]
37. Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Coughlin G; Dunglison N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Samaratunga H
Histopathology; 2019 Jan; 74(2):284-290. PubMed ID: 30129659
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas.
Seo AN; Yoon G; Ro JY
Adv Anat Pathol; 2017 Mar; 24(2):65-77. PubMed ID: 28181950
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
40. [Provisional renal cell carcinoma subsets following the 2016 WHO classification].
Jenei A; Hes O; Kuthi L
Orv Hetil; 2020 Jan; 161(3):83-94. PubMed ID: 31928058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]